Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes-Reference-Cited by-同舟云学术

Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes

Published:2007-05 Issue:3 Volume:9 Page:290-299
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Klein O.,Lynge J.,Endahl L.,Damholt B.,Nosek L.,Heise T.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2006.00685.x/fullpdf

Reference35 articles.

1. The Action Profiles of Human NPH Insulin Preparations

2. Variability of Insulin Absorption and Insulin Action

3. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

4. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

5. Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus;Expert Review of Endocrinology & Metabolism;2024-02-20

2. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic;Computational Biology and Chemistry;2023-10

3. Insulin: The Journey Continues;Journal of Marine Medical Society;2023-09-01

4. An overview of recent advances in insulin delivery and wearable technology for effective management of diabetes;Journal of Drug Delivery Science and Technology;2022-09

5. How to Achieve Sufficient Endogenous Insulin Suppression in Euglycemic Clamps Assessing the Pharmacokinetics and Pharmacodynamics of Long-Acting Insulin Preparations Employing Healthy Volunteers;Frontiers in Pharmacology;2022-07-22